Condor Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Condor Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-85	Closed	-$82K	–	191
2016 Q3	$82K	Hold	85	–	–	0.02%	183
2016 Q2	$122K	Hold	85	–	–	0.03%	176
2016 Q1	$105K	Buy	+85	New	+$98K	0.03%	177
2015 Q4	–	Sell	-43	Closed	-$62K	–	195
2015 Q3	$62K	Hold	43	–	–	0.02%	190
2015 Q2	$95K	Hold	43	–	–	0.02%	191
2015 Q1	$128K	Buy	43 +37	+617%	+$118K	0.03%	187
2014 Q4	$19K	Sell	6 -33	-85%	-$117K	0.01%	172
2014 Q3	$138K	Buy	39 +6	+18%	+$23.3K	0.04%	166
2014 Q2	$127K	Buy	33 +7	+27%	+$26.3K	0.04%	166
2014 Q1	$108K	Buy	26 +23	+767%	+$103K	0.03%	159
2013 Q4	$12K	Sell	3 -15	-83%	-$56.8K	﹤0.01%	158
2013 Q3	$72K	Hold	18	–	–	0.02%	160
2013 Q2	$180K	Buy	+18	New	+$199K	0.07%	158

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Condor Capital Management's FRTX Position: Q4 2016 in Review

Condor Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2016, closing a stake of 85 shares — an estimated $82K sold.

Condor Capital Management first reported a position in FRTX in Q2 2013 and held it in 13 quarters. The position peaked at $180K in Q2 2013. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

Condor Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Condor Capital Management sold 85 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $82K.
Condor Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
Condor Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $180K in Q2 2013.
26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Condor Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.